Mercy Hospital St. Louis is adding a noninvasive technology that directs sound waves to destroy liver tumors. The hospital is slated to become the first in Missouri and among the first 100 in the U.S. to use the Edison histotripsy…
Author: Ella Jeffries
Mammography use among U.S. women remained largely stable from 2002 to 2022, though several subgroups — particularly younger women — experienced notable declines, a study found. The study, led by researchers from Washington University in St. Louis and published March…
The FDA has approved a new device to treat adults with locally advanced pancreatic cancer in combination with gemcitabine and nab-paclitaxel. The device called Optune Pax, is a portable, wearable system that uses low-intensity electric fields to disrupt cancer cell…
AstraZeneca’s LATIFY phase 3 trial evaluating ceralasertib in combination with Imfinzi did not meet its primary endpoint of overall survival in patients with advanced non-small cell lung cancer. Ceralasertib is an oral ATR kinase inhibitor designed to enhance anti-tumor immune…
Hartford HealthCare’s St. Vincent’s Medical Center in Bridgeport, Conn., has received a $15 million gift from the estate of Neil Mellen to expand and modernize its inpatient oncology unit. The donation — one of the largest in Hartford HealthCare’s history…
Advertisement
New Hyde Park, N.Y.-based Northwell Health and San Antonio-based START Center for Cancer Research opened a $5.7 million early-phase clinical trial facility Dec. 16 at Northwell’s R.J. Zuckerberg Cancer Center in Lake Success, N.Y. The Northwell-START New York-Long Island center…
Radiation therapy offered no survival benefit for women with early-stage breast cancer who received mastectomy, lymph node surgery and cancer drugs, according to an international study published Nov. 5 in The New England Journal of Medicine. The phase 3 randomized…
AstraZeneca’s LATIFY phase 3 trial evaluating ceralasertib in combination with Imfinzi did not meet its primary endpoint of overall survival in patients with advanced non-small cell lung cancer. Ceralasertib is an oral ATR kinase inhibitor designed to enhance anti-tumor immune activity, while…
Hartford HealthCare’s St. Vincent’s Medical Center in Bridgeport, Conn., has received a $15 million gift from the estate of Neil Mellen to expand and modernize its inpatient oncology unit. The donation — one of the largest in Hartford HealthCare’s history…
New Hyde Park, N.Y.-based Northwell Health and San Antonio-based START Center for Cancer Research opened a $5.7 million early-phase clinical trial facility Dec. 16 at Northwell’s R.J. Zuckerberg Cancer Center in Lake Success, N.Y. The Northwell-START New York-Long Island center includes 14…